The terms of the agreement entail the acquisition of all of the outstanding shares of Masimo common stock by Danaher ...

We're exiting our position in Danaher , selling 200 shares at roughly $208 each. Our early spring cleaning of the portfolio ...

Danaher Corporation, a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation a leading specialty diagnostics provider ...

Irvine medical device maker Masimo has entered an agreement to be acquired by Danaher, owner of Brea-based Beckman Coulter, in a $9.9 billion deal.

The move reflects a broader industry shift toward consolidation and integrated care, as large healthcare companies seek scale ...

MASI will be acquired by Danaher for $9.9B in cash, sending shares soaring as the medtech firm prepares to join DHR's Diagnostics segment.

Diagnostics business unit News of the agreement sent Masimo’s Nasdaq-listed stock price up in value by more than 30 per cent, with the $180-per-share purchase price last achieved just under a year ago ...

On February 16, 2026, Masimo Corporation agreed to be acquired by Danaher Corporation in an all-cash merger that values Masimo at $180 per share, or about $9.9 billion, with the deal unanimously ...

On February 17, 2026, Danaher announced a definitive agreement to acquire Masimo Corporation, a specialty diagnostics company known for pulse oximetry and patient monitoring solutions used primarily ...

Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics ...

Danaher is buying Masimo for $180 per share in cash. Here why MASI could push DHR stock higher in 2026. Danaher shares are ...

For those who like to run the numbers, Danaher claims it is paying “18x estimated 2027 EBITDA, or 15x 2027 estimated EBITDA ...